Alan Leff to Lipopolysaccharides
This is a "connection" page, showing publications Alan Leff has written about Lipopolysaccharides.
Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. Am J Respir Cell Mol Biol. 2011 Mar; 44(3):361-8.
Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation. Am J Respir Cell Mol Biol. 2015 Feb; 52(2):152-61.
Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. Am J Respir Cell Mol Biol. 2012 Nov; 47(5):688-97.
Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur Respir J. 2013 Jan; 41(1):165-76.
Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res. 2012 Jan 18; 13:4.
Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol. 2009 Jun; 296(6):L879-87.